HBW Advisory Services LLC Invests $533,000 in Invesco Pharmaceuticals ETF $PJP

HBW Advisory Services LLC acquired a new position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 5,097 shares of the company’s stock, valued at approximately $533,000. HBW Advisory Services LLC owned approximately 0.14% of Invesco Pharmaceuticals ETF at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Flagship Harbor Advisors LLC boosted its holdings in Invesco Pharmaceuticals ETF by 1.8% during the 4th quarter. Flagship Harbor Advisors LLC now owns 6,049 shares of the company’s stock valued at $632,000 after acquiring an additional 105 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in Invesco Pharmaceuticals ETF by 5.7% during the 3rd quarter. Northwestern Mutual Wealth Management Co. now owns 2,791 shares of the company’s stock valued at $258,000 after acquiring an additional 150 shares during the period. Jones Financial Companies Lllp boosted its holdings in Invesco Pharmaceuticals ETF by 11.6% during the 1st quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock valued at $210,000 after acquiring an additional 252 shares during the period. Joseph Group Capital Management boosted its holdings in Invesco Pharmaceuticals ETF by 4.2% during the 3rd quarter. Joseph Group Capital Management now owns 22,131 shares of the company’s stock valued at $2,047,000 after acquiring an additional 889 shares during the period. Finally, CIBC Bancorp USA Inc. purchased a new stake in Invesco Pharmaceuticals ETF during the 3rd quarter valued at about $203,000.

Invesco Pharmaceuticals ETF Price Performance

Shares of PJP stock opened at $106.37 on Wednesday. The stock has a market capitalization of $408.46 million, a PE ratio of 15.59 and a beta of 0.47. Invesco Pharmaceuticals ETF has a 1-year low of $75.87 and a 1-year high of $110.81. The business has a 50-day moving average of $105.55 and a 200 day moving average of $103.09.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.